文献速递类风湿关节炎其他结缔组织病

类风湿关节炎与多关节型幼年特发性关节炎难治性疾病定义的系统综述

Summarizing current refractory disease definitions in rheumatoid arthritis and polyarticular juvenile idiopathic arthritis: systematic review.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

该研究通过系统检索6个医学数据库(1998年1月至2020年3月),筛选6251篇文献,纳入646篇,旨在明确RA和多关节型JIA中难治性疾病的定义及其关键组成部分。研究发现难治性定义存在41个组成部分,归为三大主题:对多种不同作用机制药物的抵抗(通常≥2种bDMARD)、症状和疾病活动持续、其他促成因素;最常用术语为「难治性」(80%),但仅16.9%明确报告定义生成方式。作者呼吁建立统一明确的定义以便于研究比较和患者识别。

要点

  • 难治性定义核心是对多种不同机制药物抵抗且症状与高疾病活动持续。
  • 最常用术语为「难治性」,但仅少数报告定义生成方式。
  • 定义异质性大,亟需统一标准以便研究比较和患者识别。

核心结论

  • 难治性疾病被定义为对多种不同作用机制药物的抵抗,伴持续躯体症状和高疾病活动,并包括其他促成因素。

研究设计与样本

  • 系统综述,检索6个医学数据库的英文文献,时间范围为1998年1月至2020年3月,并辅以手动检索(PROSPERO注册号CRD42019127142)。

主要发现

  • 共筛选6251项研究,646项符合纳入标准;其中581项应用无应答标准,65项提供了难治性定义/描述。
  • 从无应答研究中识别出39个不同组成部分,涉及多种疾病活动度指标,强调尽管使用一种或多种bDMARD仍存在持续疾病活动和症状。
  • 从明确定义难治性的论文中识别出41个组成部分,归为三大关键主题:对多种不同作用机制药物抵抗(通常≥2种bDMARD)、症状和疾病活动持续、其他促成因素。
  • 最常用术语为「难治性」(80%),仅16.9%明确报告定义如何生成(如临床经验或统计方法)。

关键数值与推荐

  • 难治性定义关键主题包括:对多种不同作用机制药物抵抗(通常≥2种bDMARD)、症状和疾病活动持续、其他促成因素。
  • 在提供明确难治性定义的论文中,共识别出41个组成部分。
  • 80%的论文使用「难治性」这一术语,16.9%报告了定义生成方式。

临床怎么用

  • 临床中识别难治性RA或多关节型JIA患者时,应关注对≥2种bDMARD抵抗且疾病活动与症状持续的情况,并考虑其他促成因素。
  • 鉴于定义异质性大,研究比较和患者识别困难,建议在临床实践和研究中采用统一明确的难治性定义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To identify how refractory disease (or relevant terminology variations) in RA and polyarticular JIA (polyJIA) is defined and establish the key components of such definitions. METHODS: Searches were undertaken of English-language articles within six medical databases, including manual searching, from January 1998 to March 2020 (PROSPERO: CRD42019127142). Articles were included if they incorporated a definition of refractory disease, or non-response, in RA/polyJIA, with clear components to the description. Qualitative content analysis was undertaken to describe refractory disease in RA/polyJIA and classify each component within each definition. RESULTS: Of 6251 studies screened, 646 met the inclusion criteria; 581 of these applied non-response criteria while 65 provided refractory disease definitions/descriptions. From the non-response studies, 39 different components included various disease activity measures, emphasizing persistent disease activity and symptoms, despite treatment with one or more biologic DMARD (bDMARD). From papers with clear definitions for refractory disease, 41 components were identified and categorized into three key themes: resistance to multiple drugs with different mechanisms of action, typically two or more bDMARDs; persistence of symptoms and disease activity; and other contributing factors. The most common term used was 'refractory' (80%), while only 16.9% reported explicitly how their definition was generated (e.g. clinical experience or statistical methods). CONCLUSION: Refractory disease is defined as resistance to multiple drugs with different mechanisms of action by persistence of physical symptoms and high disease activity, including contributing factors. A clear unifying definition needs implementing, as the plethora of different definitions makes study comparisons and appropriate identification of patients difficult.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Chaplin H, Carpenter L, Raz A, et al. Summarizing current refractory disease definitions in rheumatoid arthritis and polyarticular juvenile idiopathic arthritis: systematic review. Rheumatology (Oxford). 2021. PMID: 33710321. doi:10.1093/rheumatology/keab237

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。